1. Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials
   Bruno Almeida Costa et al, 2024, Clinical Lymphoma Myeloma and Leukemia CrossRef
2. Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal plasmacytomas: a retrospective study in a single center
   Shuiqing Xu et al, 2024, Hematology CrossRef